0
0
Biopharma company BioNTech advocates for a possible booster vaccination with its existing vaccine. Antibody levels would have been significantly higher after a third vaccination.
Initial data on third Corona vaccination
“We think right now it’s best to proceed with a booster dose for the existing strain of the virus to get the situation under control,” company CEO Ugur Sahin said Monday. Patients who received a third dose of the same Corona vaccine showed significantly higher antibody levels than after the second dose, he said.
Corona vaccine not to be adapted for mutations at this time
It is not clear what virus variants might emerge in the coming months, Sahin explained. Therefore, it would not make sense to adapt the vaccine now.
- source: vienna.at/APA/picture: pixabay.com
This post has already been read 564 times!
